Dohj, LLC Amgen Inc Transaction History

Dohj, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $1.26 Million - $1.47 Million	-5,680 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $81,575 - $97,141	-377 Reduced 6.22%	5,680 $1.35 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $27,688 - $30,792	118 Added 1.99%	6,057 $1.41 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $14,440 - $17,720	73 Added 1.24%	5,939 $1.45 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $118,820 - $157,588	652 Added 12.5%	5,866 $1.19 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $986,540 - $1.27 Million	5,214 New	5,214 $1.26 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Dohj, LLC, based on Form 13F filings with the SEC.

Stay updated on Dohj, LLC with notifications on news.